Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 8-K Event Auditor change · Other events
  2. 8-K Event Other events
  3. 8-K Event Executive or director change
  4. 4 Grant or award Chief Financial Officer acquired 61,750 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations · Other events
  9. 8-K Event Other events
  10. 8-K Event Regulation FD disclosure
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change · Other events
  19. UPLOAD Other SEC-generated Letter
  20. 8-K Event Other events

Page 31 of 64 · 1,278 filings